(Q54776294)

3 June 2018

title

Bleomycin inhibits adipogenesis and accelerates fibrosis in the subcutaneous adipose layer through TGF-β1. (English)

1 reference

3 June 2018

1 reference

Shiro Ohgo

1

1 reference

3 June 2018

Seiji Hasegawa

2

1 reference

3 June 2018

Yuichi Hasebe

3

1 reference

3 June 2018

Hiroshi Mizutani

4

1 reference

3 June 2018

Satoru Nakata

5

1 reference

3 June 2018

Hirohiko Akamatsu

6

1 reference

3 June 2018

publication date

1 November 2013

1 reference

3 June 2018

published in

Experimental Dermatology

1 reference

3 June 2018

volume

22

1 reference

3 June 2018

issue

11

1 reference

3 June 2018

page(s)

769-771

1 reference

3 June 2018

Mechanisms of skin fibrosis in systemic sclerosis

cites work

1 reference

Rosiglitazone abrogates bleomycin-induced scleroderma and blocks profibrotic responses through peroxisome proliferator-activated receptor-gamma

21 January 2018

1 reference

Regulation of Matrix Remodeling by Peroxisome Proliferator-Activated Receptor-γ: A Novel Link Between Metabolism and Fibrogenesis

21 January 2018

1 reference

Cellular and molecular mechanisms of bleomycin-induced murine scleroderma: current update and future perspective

21 January 2018

1 reference

Fibrosis in systemic sclerosis: Emerging concepts and implications for targeted therapy

21 January 2018

1 reference

Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities

21 January 2018

1 reference

Transforming growth factor beta as a therapeutic target in systemic sclerosis

21 January 2018

1 reference

Role of endoglin in fibrosis and scleroderma

21 January 2018

1 reference

What are subcutaneous adipocytes really good for?

21 January 2018

1 reference

Adipose-derived stem/progenitor cells: roles in adipose tissue remodeling and potential use for soft tissue augmentation

21 January 2018

1 reference

Emerging roles for the transforming growth factor-{beta} superfamily in regulating adiposity and energy expenditure

21 January 2018

1 reference

The adipokine adiponectin has potent anti-fibrotic effects mediated via adenosine monophosphate-activated protein kinase: novel target for fibrosis therapy

21 January 2018

1 reference

Adiponectin promotes hyaluronan synthesis along with increases in hyaluronan synthase 2 transcripts through an AMP-activated protein kinase/peroxisome proliferator-activated receptor-α-dependent pathway in human dermal fibroblasts

21 January 2018

1 reference

Adiponectin expression is decreased in the involved skin and sera of diffuse cutaneous scleroderma patients.

21 January 2018

1 reference

Serum adiponectin levels inversely correlate with the activity of progressive skin sclerosis in patients with diffuse cutaneous systemic sclerosis.

21 January 2018

1 reference

Levels of adiponectin, a marker for PPAR-gamma activity, correlate with skin fibrosis in systemic sclerosis: potential utility as biomarker?

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/EXD.12256

1 reference

3 June 2018

1 reference

3 June 2018